|
聯邦制藥國際控股有限公司, 03933.HK - 綜合損益表 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
營業額 |
8,392,600 |
7,510,586 |
6,826,645 |
7,062,571 |
7,694,563 |
8,029,835 |
7,648,443 |
7,021,624 |
6,405,039 |
6,502,817 |
4,643,177 |
3,755,856 |
2,594,937 |
2,080,479 |
1,720,442 |
經營溢利 |
951,769 |
567,465 |
122,889 |
-43,641 |
228,667 |
1,092,531 |
354,826 |
192,228 |
177,913 |
1,163,280 |
693,370 |
532,530 |
558,341 |
215,892 |
183,813 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
聯營公司 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5,886 |
-8,342 |
除稅前經營溢利 |
841,652 |
793,879 |
68,951 |
-154,551 |
235,422 |
663,546 |
901,348 |
248,313 |
183,189 |
1,163,280 |
693,370 |
532,530 |
558,341 |
221,778 |
175,471 |
稅項 |
199,888 |
110,951 |
-12,807 |
156,743 |
125,064 |
-17,530 |
853,311 |
86,336 |
78,916 |
189,123 |
151,927 |
102,361 |
47,878 |
47,940 |
42,526 |
少數股東權益 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16,379 |
股東應占溢利 |
641,764 |
682,928 |
81,758 |
-311,294 |
110,358 |
681,076 |
48,037 |
161,977 |
104,273 |
974,157 |
541,443 |
430,169 |
510,463 |
173,838 |
116,566 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
675,732 |
741,039 |
733,516 |
824,128 |
733,085 |
707,437 |
569,992 |
536,410 |
457,239 |
414,110 |
333,238 |
248,249 |
181,779 |
188,315 |
110,958 |
利息 |
285,147 |
268,876 |
281,356 |
291,663 |
405,078 |
478,635 |
471,321 |
349,712 |
199,729 |
114,818 |
105,770 |
117,181 |
79,961 |
85,485 |
71,766 |
利息撥作發展資本 |
4,309 |
21,979 |
14,621 |
19,225 |
55,570 |
106,674 |
270,175 |
134,781 |
44,980 |
23,000 |
17,280 |
0 |
0 |
0 |
24,413 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
23.75 |
13.98 |
-18.57 |
-101.42 |
53.12 |
-2.64 |
94.67 |
34.77 |
43.08 |
16.26 |
21.91 |
19.22 |
8.58 |
21.62 |
24.24 |
營業額增長(%) |
11.74 |
10.02 |
-3.34 |
-8.21 |
-4.18 |
4.99 |
8.93 |
9.63 |
-1.5 |
40.05 |
23.63 |
44.74 |
24.73 |
20.93 |
43.36 |
股東應占溢利增長(%) |
-6.03 |
735.3 |
0.0 |
0.0 |
-83.8 |
1320.0 |
-70.34 |
55.34 |
-89.3 |
79.92 |
25.87 |
-15.73 |
193.64 |
49.13 |
-11.77 |
核數師意見 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|